Rakesh Jhunjhunwala-Backed Concord Biotech Files For IPO (Public Offer)

Concord Biotech IPO: Rare Enterprises-backed Concord Biotech has filed draft papers with the capital markets regulator SEBI to mop up funds through an initial public offering (IPO).

from NDTV Profit-Latest https://ift.tt/EraCVnm
via